How Poor Start-Up/Shutdown Practices Lead to Deviations
How Poor Start-Up/Shutdown Practices Lead to Deviations How Poor Start-Up/Shutdown Practices Lead to Deviations in Pharmaceutical Manufacturing Robust start-up and shutdown procedures are critical elements of pharmaceutical Good Manufacturing Practice (GMP) compliance. In the manufacturing environment, any deviation from established procedures during equipment start-up or shutdown can have serious consequences—including contamination, product quality impact, regulatory…
Read More “How Poor Start-Up/Shutdown Practices Lead to Deviations” »